Healtheuniverse phase one international research efforts to commercialize stem cell applications in the $15 bn plastic, reconstructive, and cosmetic surgery market.

(From Chemical Business NewsBase - Press Release)

Healtheuniverse Inc announced that phase one international research efforts are focused on being the first to commercialize stem cell applications in the $15 bn worldwide plastic surgery and cosmetic surgery market. The company intends to sell its proprietary technology through packaged products and licensing agreements, once human clinical trials are completed, to plastic, reconstructive, and cosmetic surgeons as a simple way for the industry to utilize our proprietary technology worldwide. Healtheuniverse phase one research is utilizing …